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Abstract 
Haematopoiesis originates from haematopoietic stem cells (HSC), whose functions and 
maintenance are regulated in both cell- and non-cell autonomous ways. The surroundings 
generate a specific niche or microenvironment, in which HSC nest, that also influences their 
self-renewal characteristics. The cellular players in the haematopoietic niche include vascular 
beds, mature blood cells, and various cells of stromal and neural origin. Stromal cells are 
regulated by the sympathetic nervous system, which is responsible for fluctuation of the HSC 
into the bloodstream in a circadian manner. It is becoming increasingly clear, that the neural 
regulation has more pronounced effects on HSC. For instance, in diseases such as 
myeloproliferative neoplasms, HSC-derived inflammation together with neuropathy induce 
apoptosis in stromal compartment, which subsequently allows expansion of mutant HSC 
(Arranz et al., 2014). The niche is also important in leukaemia, with malignant cells 
reprogramming certain cellular niche components. Ageing of the haematopoietic system is also 
heavily influencing HSC abilities, causing immunosenescence and clonal abnormalities that 
can be considered as pre-leukaemic lesions. The age-related changes in HSC niche are scarcely 
investigated, particularly in the context of malignancies. 
In this study, potential leukaemic transformation was studied throughout ageing in mice, 
and the same animals were also monitored for changes in the microenvironment of the bone 
marrow. Investigated mice presented a haematopoietic phenotype typical for development of 
haematopoietic malignancy, and we show that this phenotype is remarkably aggravated in old 
mice. Changes in myeloid cells and HSC, with severe extramedullary haematopoiesis may 
indicate leukaemic transformation that should be followed up in future work. Mesenchymal 
cells were found to undergo similar reduction in healthy and leukaemic mice in the old age. 
Our data points to CD90-expressing mesenchymal cells as a niche component that should be 
considered in the future. Augmented inflammatory status related to interleukin 1 was detected 
in those individuals, but regulation through interleukin 1 receptor expression seems to be absent 
in old transgenic mice. In summary, the data presented here seems to point to ageing as an 
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Theoretical background 
1 Bone marrow is a complex and efficient factory of 
blood cells 
Adult stem cells are the reservoir for the organism regeneration capabilities, thanks to 
their replenishing potential, that can steadily react to changes in demand for differentiated cells. 
As the organism grows older, decay of cells and accumulation of molecular damage increases. 
The cell turnover capabilities cannot cope with these augmented needs, and the basic functions 
of tissues are altered.  
Generation of haematopoietic cells in the bone marrow is the most abundant stem cell 
driven process in the entire organism (Ogawa, 1993). Given the versatile fate of resulting cells, 
and their multiple crucial functions, it is of great importance to elucidate the factors that 
influence the steps of their development. Haematopoietic Stem Cells (HSC) are a rare subset of 
cells that reside mostly in the bone marrow, and give rise to all blood cell subsets. Those cells 
can remain in a quiescent, nearly dormant state, seldom dividing, in order to act as a reserve in 
times of need. The typical proliferative property of stem cells that ensures tissue homeostasis 
is asymmetric cell division. It allows maintenance of the stem pool and generation of functional 
differentiated cells in parallel. As differentiation progresses, the cells lose pluripotency and 
commit to certain lineages (Orkin & Zon, 2008). HSC from Long-Term (LT) type decrease in 
self-renewing capacity and become Short-Term (ST) HSC, that then progress into multipotent 
progenitor (MPP) cells. The MPP further become Common Myeloid Progenitors (CMP) and 
Common Lymphoid Progenitors (CLP) (Figure 1). Further steps are more complex as various 
blood cells require multiple factors to develop and migrate to different sites of bone marrow or 
other organs.  
Recent evidences suggest nevertheless that in certain circumstances the lineage 
commitment can occur already in cells phenotypically defined as HSC that still maintain their 
self-renewing potential. In this way, myeloid-restricted progenitors with long-term 
repopulating activity can arise from HSC (Yamamoto et al., 2013). Myeloid-biased multipotent 
progenitors tend to increase in numbers when the bone marrow regenerates after stress (Pietras 
et al., 2015). Additionally, a subset of HSC expressing von Willebrand factor (vWF) is platelet-
primed in both LT and ST stages (Sanjuan-Pla et al., 2013). Lineage tracing study of fetal-like 
tyrosine kinase (flt3) L-S+K- cells shown that these cells are a ST-HSC, as primarily they can 
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reconstitute all the cells of both myeloid and lymphoid lineage. Nevertheless, those cells only 
possess long-term reconstitution abilities to differentiate only into lymphoid cells when 
transplanted. It is therefore a lymphoid biased population with self-renewal potential 
(Adolfsson et al., 2005). These recent discoveries suggest that, with development of more 
precise detection methods: better markers for flow cytometry, single-cell based analysis, 
lineage-tracing studies- the differentiation routes of HSC can be discovered as more complex 
than initially considered. Further, there are multiple external factors that may influence the cells 
both in homeostasis and in pathological states. 
 
Figure 1 - Hierarchical model of haematopoietic differentiation compared to the more flexible newly proposed model. 
Highly quiescent LT-HSC are believed to decrease in self-renewal ability into ST- HSC that lose it completely. 
Further they become multipotent progenitor cells (MPP) that differentiate into common myeloid and lymphoid 
progenitors. CMP can either form megakaryocyte/erythrocyte progenitors (MkEP), or generate 
granulocyte/monocyte progenitors (GMP). CLP differentiate directly into pro-pre B and T lymphocytes that undergo 
further maturation outside bone marrow. Novel methods enable to monitor cell fates more closely, leading to a 
discovery of progenitor cells with self-renewing abilities, as well as shifts in fate of multipotent cells, which become 
phenotypically biased toward specific lineage -illustrated as MPP 2-4. Adapted from Pietras et al., 2015, Cell Stem 
Cell 17, 35–46. Graphics adapted from Blausen.com staff (2014). WikiJournal of Medicine. 
Early haematopoietic activity in foetal stages primarily takes place in liver, spleen and 
lymph nodes, and moves to bones as they are developing. In adult homeostatic conditions, 
extramedullary haematopoiesis occurs at a very low level, and accelerates in severe bone 
marrow failures and blood malignancies (T. W. Kim & Chang, 2010). In humans, the adipose 
tissue tends to predominate in long bone cavities of adults, giving it the name of yellow marrow. 
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Therefore main sites of haematopoiesis change during the lifetime, from long bones filled with 
red marrow in kids, to flat bones in adults.  
The architecture of the bone marrow can differ slightly depending on the bone, but 
overall it follows the same pattern: a tightly packed net of stromal cells, perforated by rich 
vasculature that spreads from the centre towards the endosteal part, in direct proximity to the 
bone. The architecture created by stromal cells resembles a sponge, and all the extracellular 
spaces are occupied by blood cells in various stages of development (Farhi, 2009). Even though 
there is not a visible compartmentalisation within the tissue, there are areas of diverse 
functionality, described based on which cells tend to home within them.  
Functional granulocytes are stored in the bone marrow. Their activation and release to 
the bloodstream depends on the release of the cytokine granulocyte colony-stimulating factor 
(G-CSF), from surrounding endothelial cells but also macrophages. The latter forms a specific 
type of feedback loop, as their release of G-CSF is a response to apoptosis of neutrophils re-
entering bone marrow from the circulation. Megakaryocytes residing in the bone marrow are 
incorporated in subendothelial zones of sinusoids (fenestrated capillaries) through which their 
protrusions enter the blood vessel and release platelets. They also release extracellular 
substances that induce their maturation and create a specific niche environment (Malara et al., 
2014). Immature erythrocytes establish a particular structure with a macrophage in the centre, 
called erythroblastic island. The macrophages in this structure provide substrates for 
haemoglobin synthesis and growth factors. The islands are distributed evenly throughout the 
bone marrow, nevertheless electron microscopy studies show that with increased differentiation 
of proerythroblasts, entire islands tend to migrate toward sinusoids (Yokoyama, Etoh, 
Kitagawa, Tsukahara, & Kannan, 2003). 
HSC require a specific niche that allows them to maintain their self-renewal potential. 
In contrast to more differentiated cells, HSC are more influenced by the surroundings (mature 
blood cells are preconditioned to be able to survive in the circulation that is a much more 
variable environment). Their microenvironment must provide cues that will maintain their pool 
in homeostasis. Such influencing environment was postulated in 1978, and described as stem 
cell niche (Schofield, 1978). In many cases, the niche not only assures the home for cells, by 
maintaining their metabolic requirements and specific oxygen levels, but also provides stimuli 
that push cells into differentiation, or in contrary, induces their quiescence. 
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1.1 The importance of the HSC niche 
In the variety of adult stem cells pools localized throughout the body, it was early 
discovered that it is not only cellular intrinsic characteristics that keep them in the “virgin” 
undifferentiated state. Stem cells outside their designated sites of residence change their 
behaviour, and lose their pluripotency. Studies in various models and tissues have enabled 
Ferraro and colleagues to describe some common features that characterize stem cell niches. 
Primarily, diverse stromal cells have a major role in creating the environment for stem cells, 
not only by direct cell-to-cell interactions but also through release of exogenous stimuli into 
interstitial fluid. This communication is bidirectional. Stem cells depend vastly on the proteins 
present in the extracellular matrix of the niche that play a crucial role in transfer of signals 
required to maintain them in homeostasis as well as support their anchorage at the site 
(Gattazzo, Urciuolo, & Bonaldo, 2014). Blood vessel proximity is also pivotal for stem cells, 
to provide access to nutrients and systemic signals from the organism, as well as to enable cell 
movement into and out of the niche (Ferraro, Celso, & Scadden, 2010). Lastly, neural stimuli 
plays an important factor, as innervation integrates signals from other organs and can induce 
stem cells egress or differentiation (Mendez-Ferrer, Lucas, Battista, & Frenette, 2008).  
Even though the bone marrow stem cell niche was the first one to be described, there 
still a lot about its interactions that remains to be elucidated. To the date, investigators do not 
cease to explore and change the concepts, searching for the cells of the highest importance for 
HSC maintenance. As a result, none of the cell subsets were discovered to carry all the 
responsibility, but multiple cell types were shown to contribute directly or indirectly in differing 
degree (Figure 2).  
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Figure 2 - Generic overview on the network of interactions in the stem cell niche. Humoral signals are delivered by 
closest blood vessels. Endothelial or stromal cells are responsible for providing a proper structural support, in 
response to the stem cell physical needs, and often carry additional paracrine function. This compartment is 
sensitive to signals from nervous system. Stem cells also have certain metabolic and oxygen level requirements 
that are provided by the niche. Lane et al., Nature Biotechnology 2014 32(8):795-803. Reprinted by permission. 
1.1.1 Osteoprogenitors were proposed as important HSC niche cells  
Early studies of the bone marrow HSC localization indicated that those cells tend to nest 
close to the bone, leading to an idea of endosteal niche. Co-transplantation of osteoblasts along 
bone marrow led to better results than in comparison to other cells (El-Badri, Wang, Cherry, & 
Good, 1998). Two papers published in Nature in 2003 have presented that osteoblasts play 
crucial role in HSC maintenance: lineage-negative (Lin-) Sca-1+c-Kit+ (LSK) cells were 
increased in transgenic mice with enriched osteoblast compartment through overexpression of 
bone morphogenic factor (J. Zhang et al., 2003). Administration of parathyroid hormone, 
known regulator of osteoblasts, have shown similar results (Calvi et al., 2003). Nevertheless, 
in a follow up study, in which parathormone receptor was constitutively activated in mature 
osteoblasts, influence of those cells on HSC compartment was not detected (Calvi et al., 
2012).  Several novel studies have pointed out newly transplanted HSC to home in an endosteal 
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location. It is not known whether this is not just a transient localization. The use of intravital 
microscopy enabled to monitor nesting of HSC through very thin layer of bone and indeed 
various experiments have shown they were accumulating near to the bone (Kohler et al., 2009) 
(Le et al., 2017). There are nevertheless some limiting factors to this technology that need to be 
taken under consideration, such as that stress induced by surgical manipulation that can bias 
the results, similarly to restriction of measurement to overly superficial area, as well as choice 
of calvarial bones for the study, architecture of which may not precisely correspond to long 
bones that carry main haematopoietic functions in mice. Calcium ions, released in the endosteal 
region due to constant bone remodelling processes driven by osteoclasts, was shown to 
influence quiescent HSC nesting in developing bones (Adams et al., 2006). Another factor 
secreted by osteoblasts, thrombopoietin (TPO), appear to have a major role in maintaining HSC 
in quiescent state in postnatal mice (Qian et al., 2007). Recent report has revealed that the main 
production of TPO necessary for HSC is actually carried out by hepatocytes (Decker, Leslie, 
Liu, & Ding, 2018). Finally, a novel discovery of CXC chemokine ligand 12 (CXCL12 or CXC 
chemokine subfamily), as a main HSC nesting factor, have shown lack of effect of its deletion 
in osteoblasts and their precursors on HSC (Greenbaum et al., 2013), which has shed some 
doubts about them being necessary niche creating component.  
1.1.2 Vascular and stromal HSC niche 
In a short time, novel viewpoint emerged pinpointing the importance of vasculature in 
the niche. When using signalling lymphocytic activation molecule (SLAM) receptors, 
specifically CD150 marker, HSC were reported to gather in bone marrow sinusoids, leading to 
a discovery of new putative niche cells contained within the endothelium of blood vessels in 
the bone marrow (Kiel et al., 2005). Indeed around 88% of HSC and progenitors in the mouse 
femora were located near bone marrow sinusoidal endothelium defined as laminin+/lo Sca-1−/low. 
Remaining percentage is found close to Sca-1+ laminin+ central arteries and endosteal vessels 
(Nombela-Arrieta et al., 2013). Rare HSC found within endosteal part of bone might actually 
nest in this site because they are attracted by endothelial capillaries ensheathed by perivascular 
cells specifically expressing neural/glial antigen 2 (NG2) (Kunisaki et al., 2013). Identification 
of definite marker for LT-HSC, Homeobox B5, enabled to track those cells to homogenous 
location- close to cadherin 5 expressing perivascular cells (J. Y. Chen et al., 2016). 
Characterisation of HSC based on their reactive oxygen species (ROS) levels, inversely 
proportional to their quiescence, revealed that dormant cells locate in arterioles close to the 
endosteum, whereas ROShigh cells locate in perisinusoidal surfaces, where high permeability 
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exposes them to blood stream (Itkin et al., 2016). Endothelial cells have now been established 
as a pivotal niche constituent, given that they are great producers of maintenance factors for 
HSC (Ding, Saunders, Enikolopov, & Morrison, 2012). Additionally, adherence molecules 
expressed by vascular endothelial cells such as vascular endothelial growth factor (VEGF) 
(Hooper et al., 2009) and E-selectin (Winkler et al., 2012) are of great significance when it 
comes to reestablishment of HSC compartment after the transplant.  
Previously mentioned CXCL12 was discovered to have a major influence on HSC 
homing in the bone during development and B-cell maturation (Nagasawa et al., 1996). Use of 
inducible Mx1Cre model enabled to overcome CXCL12 deletion lethality, and investigate its 
role in adults, showing that signals from the chemokine, through its specific receptor CXCR4, 
are crucial for HSC survival (Velasco-Hernandez, Säwén, Bryder, & Cammenga, 2016), and 
are mostly derived from CXCL12 abundant reticular cells of stromal origin, known as CAR 
cells. Apart from CAR cells, CXCL12 is also expressed by endothelial cells, and osteoblasts 
and HSC itself in smaller amounts (Ding et al., 2012). The chemokine was proven to effect 
quiescence and proliferation states, and to induce migration and retention capabilities of HSC. 
In addition, it was recently shown that CXCR4 has a major role in protection from reactive 
oxygen species (ROS) that can cause exhaustion of self-renewing HSC (Y. Zhang et al., 2016).   
Mesenchymal stromal cells (MSC, also called mesenchymal or skeletal stem cell) are 
progenitor cells that co-reside with HSC in bone marrow, where they are responsible for 
regeneration of bone, chondrocytes, stromal cells, fibroblasts, and adipocytes. Those cells were 
first defined by heterotopic transplantation assays that led to establishment of functional bone 
ossicles, which were able to home HSC and carry out haematopoietic activity. Therefore, these 
cells carry an ability to establish proper environment for HSC (Sacchetti et al., 2007). Apart 
from that, they were scarcely studied due to lack of proper markers to visualise less 
differentiated subsets. In the beginning of the century, this field expanded rapidly. A major 
breakthrough was achieved by establishing a marker that enabled to target cells that carry all 
the fibroblast colony forming unit (CFU-F) activity, and have the ability to form mesenspheres 
that can self-renew and be serially transplanted (Mendez-Ferrer, Battista, & Frenette, 2010). 
Nestin is a neuroepithelial stem cell intermediate filament expressed in various tissues that in 
embryonal endochondral ossification traces cells of endothelial and stromal lineage. Nes-creER 
induced with tamoxifen preferentially targets nestin-expressing endothelial cells, small 
population of which persists in postnatal mice and express Cxcl12 (Ono et al., 2014). In adult 
bone marrow MSC specifically express nestin-green fluorescence protein (GFP), and loose it 
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in further stages of differentiation.  For example, parathyroid hormone administration doubled 
the amount of those cells in bone marrow and simultaneously their differentiation toward 
osteoblastic lineage. Nestin+ cells were identified, by whole-mount confocal microscopy 
through GFP expression, into two subsets: Nestin-GFPbright that have high multipotent 
reconstitution potential, but are more seldom and locate around arterioles, and Nestin-GFPdim, 
reticular-shaped cells abundantly covering sinusoids, and with low repopulating potential 
(Kunisaki et al., 2013). This distinction is still under debate (Ding et al., 2012), but it led to the 
discovery that Nestin-GFP bright cells colocalize with dormant HSC (Kunisaki et al., 2013) and 
are great producers of CXCL12 (Asada et al., 2017). Those cells, of periarterioral localization, 
express also neuron-glial antigen 2 (NG2). Depletion of NG2 causes HSC to move out of the 
arteriolar localization (Kunisaki et al., 2013). Another subset of stromal cells with major HSC 
maintenance activity was defined as Leptin receptor (LepR+) cells, carries major part of bone 
marrow stem cell factor (SCF) production. Membrane bound SCF plays a major role in 
haematopoiesis, as it is stimulating c-kit receptor expressed mainly on HSC. Sinusoidal 
endothelial cells were also pointed out as a source of SCF. Depletion of SCF expressing cells 
in Tie2-cre (endothelial) and LepR-cre mice leads to decrease in HSC number in bone marrow 
(Ding et al., 2012). Cxcl12 deletion from periarteriolar NG2+ cells, but not from sinusoidal 
LepR+ cells, caused HSC reductions and altered HSC localization in the bone marrow. Deletion 
of SCF in LepR+ cells, but not NG2+ cells, led to reductions in HSC numbers (Asada et al., 
2017). It is important to note that CAR cells are the most abundant in stromal compartment, 
and carry majority of HSC maintaining activity. Some of them express LepR and low levels of 
nestin. Thus, Nestin+ and LepR+ subsets partially overlap too, so MSC characterization varies 
among researcher approaches and immunophenotypic definition used.   
In humans, adipocytes are an abundant component of bone marrow, and their low 
frequency in mice constitutes a major drawback of this model. Studying haematopoiesis in 
mouse-tail, rich in adipocytes, has proven that genetically and pharmacologically induced 
deficiency in adipogenesis leads to increased haematopoietic recovery in irradiated mice, 
showing that adipocytes may be repressors of haematopoiesis through unknown mechanisms 
(Naveiras et al., 2009). Interestingly, adipocytes arising from LepR+ stromal cells after 
myeloablation carry some of the SCF releasing potential and actually have beneficial effect on 
haematopoietic regeneration (Zhou, 2017).  
Erythropoietin is another cytokine that influences HSC behaviour. As a stress- induced 
factor, it causes transcriptional reprogramming, acting directly on HSC and MPP 
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compartments, leading to erythroid priming, and lowering levels of all of the remaining 
haematopoietic lineages (Grover et al., 2014).  
1.1.3 Apple does not fall far from the tree 
Among constituents of the bone marrow, some of the differentiated haematopoietic cells 
also influence the fate of their ancestors. Megakaryocytes robustly co-localize in a close 
proximity to certain HSC subsets. In vivo depletion of megakaryocytes promoted HSC to 
increase proliferation, hence their repopulating ability (Bruns et al., 2014). Indeed worth noting, 
is the fact that these cells show some interesting similarities, which already gave clue about 
their possible interaction. Indeed cytokines so important to HSC, such as SCF, CXCL12, and 
TPO have their receptors also expressed in megakaryocytes, influencing their differentiation. 
Changes in Notch-1 signalling shows similar influence on both cell subsets, they share 
expression of several important transcription factors and secretion of factors that influence 
angiogenesis and vascular activity (Huang & Cantor, 2009). A recent study in vWF-GFP 
expressing cells (marker expressed in mature megakaryocytes, platelets and platelet biased 
HSC) revealed that megakaryocytes are involved in maintenance of quiescence of a subset of 
WVF+ HSC and of balanced differentiation, causing elevated myeloid output when depleted. 
As a comparison, NG2+ perivascular cells in arterioles were depleted and this resulted in 
decrease of solely lymphoid-biased HSC and their progeny (Pinho et al., 2018).     
Decrease in HSC numbers and quiescence when administering G-CSF, might not be an 
effect of depletion of osteoblastic component as it was primarily thought. Macrophage subset, 
named osteomacs because of their bone supporting function, reside in the endosteum and is also 
severely reduced. Furthermore induced apoptosis of solely those cells had an equivalent 
outcome, but their influence on HSC was thought to be indirect (Winkler et al., 2010). Hur and 
collegues revealed a signalling mechanism that ties up these two cell subsets. CD82 antigen, 
which is expressed under hypoxia, was used as a marker to define LT-HSC. CD82 activates 
protein kinase C alpha that regulates tumour growth factor-β1 (TGF-β1) pathway, all of which 
play major role in quiescence induction. Duffy antigen receptor for chemokines (DARC), 
molecule known for its ability to bind CD82, was investigated in putative niche cells, and found 
to be predominantly expressed on macrophages. When co-culturing human macrophage and 
HSC, rhDARC was proven to be responsible for CD82 expression mediated blockage of exit 
from G0 phase in HSC (Hur et al., 2016).   
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Neutrophils were also found to have specific influence on bone marrow HSC as they re-
enter the bone marrow to undergo apoptosis, when aged. It was found that neutrophil clearance 
releases cues that regulate circadian haematopoietic progenitor cell (HPC) release. This effect 
depends on macrophage activity of cell degradation, but it can also be connected to local 
inflammation induced by neutrophil lysis (Casanova-Acebes et al., 2013).  
FoxP3+ regulatory T cells express CD150, HSC marker, and CXCR4, that attracts them 
toward the HSC niche. When numbers of regulatory T cells were decreased due to CXCR4 
deletion, a decline in HSC followed. This led to investigation of possible involved HSC 
maintenance factors, uncovering the role of T cell ectonucleotidase released adenosine on HSC 
quiescence and ROS protection (Hirata et al., 2018). 
1.2 Sympathetic nervous system controls HSC in the bone 
marrow 
In murine bone marrow, efferent nerves can be associated into unique anatomical units, 
called neuroreticular complexes, in which they are connected with gap junctions of 
mesenchymal cells around blood vessels as presented in Figure 3. They can be generally found 
close to arterioles, and more seldom in sinusoids or bone marrow stroma, both myelinated and 
unmyelinated (K. Yamazaki & Allen, 1990). 
 0  
Figure 3 - Left- schematic graphics of reticular complex, and interaction with HSC. Arteriole, coloured in red, is 
wrapped in sympathetic nerve fibres (blue), covered in non-myelinating Schwann cells (yellow). Nestinbright and 
NG2+ pericytes reside in close proximity (green). Soluble tumour growth factor-β (TGFβ) is activated by integrins 
presented on Schwann cell, and interacts with correspondent receptor on HSC. Right- Reticular complex 
represented by fluorescent microscopy. VE-cadherin marks arteriolar endothelial cells, nestin indicates MSC, and 
GFAP non-myelinating Schwann cells. Image from Kunisaki et al. Figure 2d Nature 2013, 466: 829-34. Obtained 
by permission.  
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 The importance of neural signalling as a HSC niche factor emerged from a discovery, 
that depletion of galactocerebrosides, main component of myelin, significantly decreased G-
CSF mediated HSC egress (Katayama & Frenette, 2003). 
Circadian rhythm, driven by signalling from central nervous system, is not only 
prominent in blood cells in the bloodstream. It turns out that HSC egress from the bone marrow 
is tightly scheduled depending on light exposure. HSC-enriched population was found to 
express several of clock genes in different pattern than the rest of bone marrow haematopoietic 
compartment (Tsinkalovsky, Rosenlund, Laerum, & Eiken, 2005). Thorough study by Mendez-
Ferrer and colleagues pointed out exact time for peak (5 hours after beginning of the light cycle) 
and trough (2 hours after light cycle finishes) of HSC numbers in circulating blood. CXCL12 
release was also found to be involved in these steady-state circadian oscillations. Since 
sympathetic nervous system (SNS), main effector of clock genes, gives cues for osteoblast 
proliferation, and plays a role in mobilization of HSC by G-CSF, its involvement was further 
investigated. Chemical sympathectomy driven by 6-hydroxodopamine caused changes to 
circadian rhythm of HSC, showing the role of SNS fibres in bone marrow (Mendez-Ferrer et 
al., 2008). When comparing such activity in surgically sympathectomised tibia, with unaltered 
one in the same individual, it became clear that cues from SNS act on the niche by influencing 
the CXCL12 levels. In vitro culture of stromal cells presented similar effect when treated 
exclusively with β3-adrenergic agonist or antagonist. Given the commonly believed 
dependency between osteoblasts and HSC, the authors investigated expression of β-adrenergic 
receptors in this cell subset. Strikingly, they only express β2-adrenergic receptors, which 
prompted further investigation of other niche components, leading to discovery of perivascular 
mesenchymal stromal cells, expressing β3-adrenergic receptors, as the main mediator and 
receiver of SNS regulatory signals for the HSC in the bone marrow (Mendez-Ferrer, Chow, 
Merad, & Frenette, 2009). Indeed in a follow up study, catecholaminergic nervous fibres were 
found to connect with nestin+ perivascular cells in the bone marrow, leading to discovery of 
correlation between sympathectomy induced differentiation of nestin+ cells and HSC numbers 
(Mendez Ferrer et al 2010). The functional dependence and cooperation in niche forming of 
nestin-expressing MSC and neuroglial component have evolutionary roots. MSC, sympathetic 
nerves and Schwann cells arise from neural crest during embryogenesis, and become active 
along the establishment of haematopoiesis in bones. Different, mesoderm-derived subset of 
MSC is responsible for all the early endochondrogenic activity (Isern et al., 2014).  
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Non-myelinating Schwann cells cover sympathetic nerves providing them with nutrients 
and insulation from environment. Glial fibrillary acidic protein (GFAP) can be used as a marker 
of those cells with a high specificity. Regulations of circadian HSC egress are tight up to the 
norepinephrine release, with β3-adrenergic receptors downregulating CXCL12 release, and β2-
adrenergic receptors responsible for induction of clock genes (Mendez-Ferrer et al., 2010). But, 
as it happens in various niche cells, the main, signal transducing neural activity of Schwann 
cells is not the only kind of interaction it has with components of the niche.  A study by 
Yamazaki proved that those cells are crucial for maintenance of quiescence through interaction 
with HSC. After discovering that clustering of lipid raft is a main mechanism forcing HSC to 
exit from quiescence, authors searched for potential molecules that counteract the clustering 
and cause cells to hibernate. As such, smad/TGFβ pathway have already emerged as negative 
regulator of HSPC proliferation in culture (Larsson & Karlsson, 2005). Tumour Growth Factor-
β is normally expressed in a latent form that accumulates in the extracellular matrix, and it can 
be activated through a not fully understood mechanism, that is postulated to include integrin-
β8. Yamazaki and colleagues screened bone marrow for cells expressing TGFB as well as 
integrin-β8. Activating cells were also found to express GFAP, pointing to Schwann cells as 
main players in TGFβ activation in bone marrow. The study investigated also the relationship 
of the nerves with nestin+ cells, among which the cells negative for platelet-derived growth 
factor receptor α (PDGFRα), another proposed mesenchymal stromal cell marker, co-express 
GFAP by antibody stainings. Surgical denervation again was found to decrease HSC numbers, 
and no influence on PDGFRα mesenchymal cells, endothelial cells or osteoblasts was detected 
(S. Yamazaki et al., 2011). It is important to note that the possibility of secondary injury was 
not ruled out in this experiment. 
The regulation of haematopoiesis by sympathetic nervous system has been given 
increasing attention, as this compartment is especially vulnerable when perturbed, due to the 
fragile nature of the nervous cells. Neurotoxic effect, caused by chemotherapy such as cisplatin 
and vincristine, has a varying spectrum of adverse effects on HSC regeneration.  Treatment by 
4-methylcatechol, a neuroprotective agent, administered to mice during sessions of 
chemotherapy, re-established sympathetic innervation of bone marrow, accompanied by 
normalised levels of nestin+ cells, and reduced morbidity. Induction of B-adrenergic blockade 
revealed that in mice with bone marrow functions challenged by administration of 5-
fluorouracil, SNS acts in an acute manner, as the response for genotoxic insult was already 
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recorded after 24 hours (Lucas et al., 2013). Neuroprotective agents can then be beneficial when 
co-administered with chemotherapy, preserving the niche from deterioration. 
 
Figure 4 - Illustration of main interactions reported in the bone marrow vascular niche by Crane et al., Nature 
Reviews Immunology, 2017. Reprinted by permission.  
 Primary ideas about homogenous bone marrow stem cell niche was proven wrong, and 
the niche as an entity becomes replaced for an extremely complex playground for many cell 
subsets. The modern state of knowledge is illustrated on Figure 4 and contains all the major 
niche players discussed above. 
2 Malignancies of haematopoietic system 
Blood cancers may arise in all blood cells in different stages of maturation. Haematopoiesis 
is a tightly regulated process in which proliferation and differentiation capabilities of the cell 
play major role in maintaining homeostasis of the system, and mutations of genes that are 
crucial regulators of these processes are mostly the source of malignancy. Mutations inducing 
differentiation block are cause of generation of futile, aberrant cells, called blasts, leading to 
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their accumulation, which generates multi-dimensional damage to bone marrow environment 
and diminishes capabilities of whole haematopoietic system. The cells can secondarily acquire 
self-renewing potential, similar to that of stem cells, that exacerbates severity of the disease and 
resistance to therapy (Farhi, 2009).  
Malignancies are denominated by the lineage of cells from which cancerous blasts arise, 
and their level of maturity. Among them, acute leukaemias develop blasts of stem cells and 
progenitors, whereas chronic leukaemias retain differentiation, and have more mild and 
prolonged course. Two main classification systems are in use for haematologic malignancies, 
The French-American-British, based on morphology of blasts, and the World Health 
Organisation (WHO), that classifies them by genetic abnormalities, myelodysplasia-related 
changes, occurrence of the disease as secondary event, and morphology- only cases in which 
previously mentioned classifications failed. Myelodysplastic syndromes (MDS) are a 
heterogeneous group of blood diseases, in which bone marrow dysplasia is followed by bone 
marrow failure and blood cytopenias. They can be considered a pre-leukaemic condition, as ¼ 
of them results in such fate (Mufti, 2004). Hereditary leukaemias mostly emerge in childhood 
or early adolescence, whereas acquired mutations lead to development of those in advanced age 
(Weinberg, 2014). Among adults there is a high incidence of secondary myelodysplastic 
syndrome or acute myeloid leukaemia (AML), as a sequela of chemotherapy directed toward 
other type of cancer (Kollmannsberger, Hartmann, Kanz, & Bokemeyer, 1998). 
 Due to their highly proliferative character, leukaemic blasts are an easy target for 
classical chemoterapeutics, and advances in haematopoietic transplantology enabled to increase 
survival rates for young patients with leukaemia. In case of leukaemias metastasis to different 
organs is very seldom, in comparison to the main problem remaining to be solved- recurrence. 
Leukaemic blast cells are heterogeneous. A study by Lapidot and colleagues in 1994 gave rise 
to a discovery that changed the general perception of cancer propagation mechanisms. While 
transplanting cells of AML from patients to mice, they found a rare subset among them, which 
carries the ability to transfer the malignancy into mouse, whereas the majority of neoplastic 
cells does not bear such a potential (Lapidot 1994). These cells were named after their function- 
leukaemia-inducing cells, leukaemic stem cells (LSC), or more generally cancer stem cells, as 
they were later discovered in various types of solid cancers. Cancer stem cells are now 
considered to be the main source of metastasis and responsible for resistance to treatment.   
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2.1.1 Effects of malignant transformation on the HSC niche  
In oppose to solid tumours, prophylactic removal of tissue affected with malignancy is 
not an option in leukaemias. The bone marrow cannot be removed and is indispensable for the 
organism. Therefore, the site of malignancy, remains in the same, altered, and additionally 
weakened after chemotherapy, condition. Moreover, the niche, hijacked by blasts, can be used 
by them for growth and as a drug-resistance shield. When screening patients after treatment, 
bone marrow biopsies tend to show minimal residual disease that is absent in the peripheral 
blood. In vivo imaging studies on calvarial bone of severe combined immunodeficiency (SCID) 
mice, showed that vascular regions that normally attract circulating HSPC and T cells, act 
similarly for cells of acute lymphoblastic leukaemic cell line, Nalm-6, that were intravenously 
injected into mouse. Since the cell line expressed CXCR4, CXCL12-secreting activity of the 
vascular endothelial cells was measured by intravenously injected antibodies and showed to 
colocalize with leukaemic cells. In vivo flow cytometry proved that blockade of CXCR4 
resulted in almost 4-fold decrease in leukaemic cells exit from the bloodstream. Out of possible 
adherence molecule players, E-selectin was found to be expressed on the same endothelial cells, 
and when it was knocked-out, Nalm-6 cells homing was reduced by 20% (Sipkins et al., 2005). 
When transplanting the same cell line in comparison with CD34+ human enriched progenitors, 
a follow up study found the leukaemic cells to home in sites considered as haematopoietic 
progenitor cells niche, which were rich in CXCL12. Leukaemic cells, spreading within this site 
cause CXCL12 downregulation, which subsequently renders them inhabitable for healthy 
CD34+ cells, and causes them to nest in distant, unusual location in CXCR4 independent 
manner. Furthermore, in a prolonged observation, leukaemic cells residing in the niche were 
found to attract the healthy CD34+ cells, subsequently outcompeting the native niche and 
simultaneously decreasing their population. SCF was found to be the main factor responsible 
for such a behaviour, upregulated in both mice model and in leukaemia patients samples 
(Colmone et al. 2008). Studies on effect of CXCL12 on LSC resulted in an ongoing clinical 
trial on AMD3100, a CXC4 competitive antagonist administration that is expected to sensitize 
the LSC to respond to therapy (Nervi et al., 2009). 
Generation of non-obese/SCID/IL2rγnull mice enabled to follow the reconstitution 
pattern of xenotransplanted primary AML cells with better engraftment and prolonged survival 
of mice after transplantation, resulting from null mutation of IL2 receptor. Using this model, 
LSC were traced to nest mostly in the endosteal part of the bone, and survived there, 
unperturbed, after a cell cycle-dependent agent, cytarabine, was administered. Those cells, 
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which escaped apoptosis, in secondary transplant proved leukaemia-inducing potential, leading 
to a conclusion, that endosteal location carries drug resistance potential of LSC (Ishikawa et 
al., 2007). Furthermore, LSC niche-altering behaviour can be accelerated as a response to 
therapy. Nestin+, LepR+ and NG2− cells, of sinusoidal origin, are recruited into specific niche 
by Nalm-6 cells after chemotherapy. At first, expansion of MSC was observed, followed by 
their acquisition of α-SMA expression, that later transformed into fibrotic tissue. This 
maturation of MSC was recapitulated in cell culture by TGF-β1 addition, which was also found 
to be produced by LSC. Futhermore, stromal cells of the niche were found to secrete furin that 
mediated cleavage of growth/differentiation factor 15, responsible for drug resistance 
acquisition in other cancer types, acting on smad3-mediated TGF-β signalling pathway in LSC 
(Duan et al., 2014). 
Retinoic acid receptor γ (RARγ) is another niche factor that was found to be an 
important element of the bone marrow microenvironment associated with cancer progression. 
Reciprocal transplantation of RARγ-/- and RARγ+/+ bone marrow cells only gave rise to the 
disease when transplanted into knock-out mice, with donor-derived cells even from control 
disease-free RARγ+/+ mouse. Among proinflammatory cytokines, marked increase of tumour 
necrosis factor- α (TNFα) was found in all sites of haematopoiesis in RARγ-/- (Walkley et al., 
2007).  
Mind bomb-1 (Mib1) conditional knock-out mice similarly showed development of 
microenvironment-driven myloproliferative disease, both in mouse mammary tumor virus-cre 
recombinase model and Mx1-cre interferon-induced background. Malignancy arose when 
transplanting wild type haematopoietic cells into sublethally irradiated mutant mice, with 
leukaemic cells of donor origin. Moreover, leukaemic phenotype was reversed gradually after 
withdrawal of inducer molecule. Mib1, an E3 ubiquitin ligase is known to interact with all 
canonical Notch ligands, a signalling pathway that has a major role in haematopoiesis (Y. W. 
Kim et al., 2008). Nevertheless, the main cellular source of Notch signalling disruptions within 
the lekemic niche remains unknown. Deletion of Dicer1 in Osx+ osteoprogenitor compartment 
led to development of myelodysplasia in transgenic mice, with leukaemic cells arising with 
several typical mutations, but without changes to Dicer1 expression. Dicer1 is an RNase III 
endonuclease that regulates the haematopoietic differentiation, as it influences miRNA 
biogenesis. Also in this case, transplantation of healthy bone marrow into mutant mice resulted 
in development of the disease. Analysis of gene enrichment patterns in those mice 
showed upregulation of genes responsible for oseoblast maturation such as TGF-β Wnt–β-
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catenin signalling pathways. Simultanously, a gene responsible for preleukaemic condition, 
Shwachman–Diamond–Bodian syndrome (Sbds) was notably downregulated, and was 
proposed as a possible factor of leukaemia development (Raaijmakers, 2007). 
Transplantation of haematopoietic cells derived from chronic myelogenous leukaemia 
mice into an Osx-gfp recipient, showed that induction of leukaemia is followed by expansion 
of osteoblastic-GFP compartment, that leads to bone marrow fibrosis. Furthermore, to 
investigate the nesting potential of osteoblastic lineage cells, they were harvested from control 
and leukaemic mice, and cultured with HSC. When HSC was transplanted into wild type 
recipient, reconstitution of healthy HSC cultured on diseased osteolineage cells was severely 
impaired. Leukaemic stem cells, on the other hand had similar, decreased reconstituting 
abilities, regardless the growing condition. In sick mice, osteolineage cells had downregulated 
HSC retention and quiescence inducing factors, but upregulated TGF-β, responsible for 
induction of myeloid promoting programs (Schepers et al., 2013).  
PDGFRα+Sca-1+ (PαS) MSC have significant effect on the pathogenesis of Notch1-
induced T-cell Acute Lymphocytic Leukaemia mice. PαS MSC numbers were reduced, and 
their proliferative and differentiation potentials were critically perturbed, leading to overall 
increase in senescence of this cell population. Gene expression pattern of those cells was also 
altered, with downregulation of factors responsible for HPC maintenance. Reduced nesting 
capabilities was also proven in in vitro co-culture. Out of potential soluble factors that could 
elevate HPC numbers, osteoprotegerin secreted by MSC was found to play a role in p38/ERK 
pathway signalling in HPC, leading to their propagation (Lim et al., 2015). 
A study by Arranz and colleagues investigated niche interactions in myeloproliferative 
neoplasm (MPN) of JAK2 (V617F) mice, and they showed that development of the disease 
caused a significant decrease in the amount of sympathetic nerve fibres and non-myelinating 
Schwann cells in the bone marrow. This neuropathy was generated by aberrant interleukin-1β 
(IL-1β) production from mutant HSC. Subsequently, a reduction of nestin+ mesenchymal 
stromal cells was found, as a result of both neural dysfunction and IL-1β levels, which allows 
propagation of aberrant HSC (Arranz et al., 2014). 
2.1.2 AML 
In AML, malignant blasts aberrantly stop their myeloid differentiation and accumulate 
in the bone marrow and peripheral blood, and more seldom in other organs. First symptoms 
result from bone marrow insufficiency, and are manifested by thrombocytopenia and anaemia, 
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accompanied by high levels of abnormal white blood cells. Patients suffer from fatigue, weight 
loss and general decrease in immunological system functions, and without treatment, internal 
bleeding or infection can become fatal after only months after diagnosis. Primary diagnosis is 
based on detection of more than 20% of leukaemic blasts either in peripheral blood or bone 
marrow. The subset of leukaemic cells is then investigated in regard to surface marker 
phenotype, myeloperoxidase action, and histopathological characteristics. AML can reach 
curability range of 35-40% in patients under 65 years, whereas in older patients this number 
dramatically falls to maximum 5% (Alibhai, Leach, Minden, & Brandwein, 2009). Standard 
treatment involves administration of cytarabine and anthracycline that induces damage of 
cycling, differentiated cells, not specifically targeting the leukaemic blasts. Induction can be 
followed by consolidation with high dose of cytrabine that must be followed by allogenic 
haematopoietic stem cell transplant. It is nevertheless invasive approach that can only be 
conducted on patients that do not carry any comorbidities (Ferrara & Schiffer, 2013).  
2.1.2.1 Genetic landscape of AML 
Mutations, required for the development of the disease can be grouped depending on the 
role of genes they involve. Class I mutations influence proliferative capacity of the cells, 
activating RAS, nucleophosmin, receptor tyrosine kinase FLT3 or KIT receptor signalling 
pathways, are the most common among patients. Class II mutations change cell differentiation 
abilities, affecting transcription factors. They arise as fusion transcripts from chromosomal 
abnormalities (RUNX1/ETO, CBFB/MYH11, PML/RARα, MLL/AF9) as well as directly from 
mutations in transcription factors, such as MLL, RUNX1, CEBPα (De Kouchkovsky & Abdul-
Hay, 2016). Mutations in both class I and II genes are sufficient for development of leukaemias, 
whereas simultaneous mutations in III class genes often mainly influence severity of the disease 
and are more common among older patients. Epigenetic modifiers pertain to this class, such as 
TET2, DNMT3A, IDH1, IDH2, EZH2, and ASXL1 (Shen et al., 2011). Signal transducer and 
activator of transcription 3 (STAT3) phosphorylation is also a prognostic factor noticed in up 
to 50% AML, which can arise due to IL-6 signalling and mutations in tyrosine kinase receptors. 
The network of detected somatic alterations co-appearance in a cohort of AML patients is 
visualised on Figure 5 (Patel et al., 2012). Two hit model of leukaemogenesis of AML, where 
mutation of class I gene is complemented by II class mutation or chromosomal rearrangement, 
and their summed up effect causes the disease was proposed also basing on mouse studies.  
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Figure 5 - Circos diagram of relative frequency and pairwise co-occurrence of mutations in 104 newly diagnosed 
AML patients. Reproduced with permission from Patel et al. New England Journal of Medicine 2012; 366:1079-
1089. Copyright Massachusetts Medical Society. 
2.1.2.2 Effects of the HSC niche on AML progression 
Genetic landscape of AML blast cells is heterogeneous, and it is the most important factor 
of prognosis and therapy development. Nevertheless, the plethora of factors and 
interconnections that are involved in malignancy development and progression requires more 
holistic look. Previously mentioned studies on bone marrow haematopoietic niche has already 
pointed out that mesenchymal cells or neural signals can carry a specific burden to disease 
development that should be addressed. Actually, in around 5% of patients treated by 
transplantation, the recurrence of disease arises from the haematopoietic cells derived from the 
donor. It is then clear that the environment may carry malignancy-inducing activity (Dickson, 
Papadopoulos, Hedvat, Jhanwar, & Brentjens, 2014). 
The effect of mutant HSC on regulatory SNS signals, first discovered in MPN (Arranz et 
al., 2014) was also found to be prominent in AML. Transplantation of  MLL-AF9 infected LSK 
into nestin-gfp mice enabled to monitor the effect of leukaemic cell expansion on mesenchymal 
niche cells, and showed a significant decrease in nestin+ pericytes expressing NG2. Sympathetic 
fibres, marked by tyrosine hydroxylase were reduced in arteriolar zones, and so were the levels 
of their main signalling molecule- noradrenaline. MSC in mice with induced leukaemia showed 
increase in CFU-F forming capacity, with a bias toward osteoblastic colonies. Fate mapping of 
NG2-creERTM/loxp-tdTomato mice showed that the reduction of NG2 stromal cells was not 
effect of their differentiation into expanded osteoprogenitor compartment. It proves that the 
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effect of leukaemic blasts on MSC diversifies, with niche supporting cells undergoing 
apoptosis, and leukaemia propagating niche developing from another subset of stromal cells. 
The expanding compartment of osteoblast primed MSC reduced expression of adrenergic 
receptor β3 but enriched adrenergic receptor β2, which is normally expressed in osteoblasts. 
Sympathetic denervation prior to injection of leukaemic cells also propagated the level of 
human leukaemic engraftment in immunodeficient mice (Hanoun et al., 2014). It is then clear 
that sympathetic signals within the niche may contribute to propagation of the disease.  
Exosomes were found as bone marrow niche altering signals. Human and mice AML 
exosomes, injected into irradiated mice internalized mostly into endothelial and stromal cell. 
Continuous injections of exosomes for four weeks had similar outcome as propagation of 
leukaemia cells in the same mouse strain. Changes occurred in the stromal compartment, with 
increase in CD146+ immature osteoprogenitor and Sca1+ multipotent stromal cells. Analysis of 
gene expression manifested that exposure to AML endosomes causes downregulation of HSC 
and osteoblast sustaining genes such as CXCL12, interleukin-7, KITL, and induces expression 
of leukaemia-supporting genes (interleukin-3, DKK1, CCL3), and restrain osteogenesis by 
downregulation of osteocalcin, COL1A1 and IGF1. In vitro differentiation assay showed that 
mesenchymal progenitors influenced by AML exosomes skew toward adipocytes, and lowered 
osteo- and chondrocytes reconstitution. Decrease in CD166+ osteoblasts detected by flow 
cytometry, was also measured through immunohistochemistry and micro-computed 
tomography in trabecular wall volume and cortical wall thickness. In patients, osteoblast lost 
was reflected in reduced levels of osteocalcin in plasma responsible for bone formation (Kumar 
et al., 2018).  
Vascular remodelling was also documented in AML, through intravital microscopy of 
Flk1-gfp mice injected with MLL-AF9 cells.  Angiogenic sprouting was observed, concomitant 
with elevated VEGF-A levels in endothelial cells of diseased mice, but the process was 
disrupted and functional branches of vessels were not generated. Endosteal vessels were found 
to be specifically reduced probably due to increased expression of TNF and Cxcl2 by AML 
cells in this area. At the final stages of the disease- with significant reduction in vasculature, 
HSC, lower in overall number, were dramatically diminished in endosteal localisation. Indeed 
genetic enhancement of vascular compartment in mice led to a better outcome of chemotherapy, 
decreasing residual leukaemic cells, as they preferentially home in perturbed vascular spaces 
(Duarte et al., 2018). 
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3 How is ageing reflected in the haematopoietic system 
Widely known decrease in the functions of immune system- immunosenescence, anaemia 
and other common haematological insufficiencies, are frequent among older patients. 
Perturbations in blood cells numbers and functionality can be traced up high in the ladder of 
haematopoietic hierarchy, which in a way places ageing into a role of stem cell disease. As 
previously mentioned, AML has a high incidence and poor prognosis among older patients. 
Could the age-related changes in the bone marrow environment and/or in haematopoietic cells 
be a main factor for the development of the malignancy? 
3.1 HSC ageing 
The effect of ageing is well characterized in HSC. The number of phenotypically defined 
HSC can increase up to 10-fold with ageing. Contradictorily, the functionality of the cells is 
massively reduced, as they lose self-renewing potential and repopulating abilities. Therefore, 
the bone marrow in elders contains high number of progenitor cells that are not able to act to 
enforce regeneration in response to stress (Sudo, Ema, Morita, & Nakauchi, 2000). Moreover, 
the output of the haematopoiesis goes through a shift. In comparison to young individuals, old 
patients have lower levels of lymphocytes and erythroblasts, and higher levels of myeloid cells. 
Similarly to HSC, this higher output does not come along with enhanced functionality, but 
rather the opposite effect (Signer, Montecino-Rodriguez, Witte, McLaughlin, & Dorshkind, 
2007). This lineage skewing begins at the level of common myeloid progenitors, proving one 
of the novel proposed haematopoiesis model, in semi-physiological conditions (Rossi et al., 
2005). Skewing is reflected in HSC gene expression, with downregulation of lymphoid and 
upregulation of myeloid genes, and disruption in methylation patterns (Farlik et al., 2016).  
As in all ageing cells, DNA damage and telomere shortening can be tight up to decrease 
in functionality and durability. However, mice study show that overexpression of telomerase 
does not influence HSC repopulating potential. There is also no clearly indicated mutation that 
have a substantial meaning in HSC ageing, however it triggers activation of cell-intrinsic 
checkpoints: p53 and retinoblastoma, and downstream and upstream regulators such as p21, 
p53 upregulated modulator of apoptosis, sestrins, exonuclease 1, ataxia telangiectasia mutated, 
ATR, p16INK4a and p19ARF. All of them, although likely aimed at clearing the damage, they 
may impair stem cell maintenance through prolonged action (Sperka, Wang, & Rudolph, 2012).  
Age-related clonal haematopoiesis is a phenomenon that gives myeloid malignancies 
evolutional advantage in old patients. Mutations normally associated with myeloid leukaemia: 
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DNMT3A, JAK2, TET2, ASXL1, SF3B1 and SRSF, appear in expanded number of HSPC clones, 
in otherwise healthy individuals, without any other symptoms of malignancy (Shlush, Zandi, 
Itzkovitz, & Schuh, 2015). Icelandic population study revealed that clonal haematopoiesis, 
manifested just by accumulation of a specific cell subset, not necessarily including any common 
mutations, is increasingly widespread with ageing, and almost reaches the point of inevitability 
(Zink et al., 2017). 
3.2 When the niche is getting old and weary 
Studies show that HSC tend to change their location when aged, and reside further from 
the endosteum. Given the importance of niche factors influencing HSC, this behaviour clearly 
indicates that either HSC are losing their ability to integrate into proper site and/or the niche 
itself is also changed by ageing process. 
A peculiar study of rejuvenation capabilities of the young environment was presented by 
Mayack and colleagues. They used a challenging parabiotic mouse model, obtained by surgical 
connection of circulatory systems of two mice. It enabled to compare pair of heterochronic 
individuals with joint system with pairs of young and old also joint into parabionts as a control 
group. Even though dramatic, the procedure does not normally induce changes in the 
frequencies of HSPC, which were the cells of interest. The model carries major flaws that arise 
from differences among individuals that can be compared to the problems that can arise with 
normal blood transfusion in humans, in addition to the major surgery and poor welfare of the 
animals thereafter. Even though genetic landscape of the individuals used is considerably 
similar, as much it can be in an inbred strain and among siblings, joining of circulations carries 
considerable perturbations for immune system and other systemic problems, not to mention the 
quality of life of the individuals after the procedure, all of which leads to very short life span of 
joined individuals. Thus, observations on this model can only be conducted for short-term, but 
it can be used as a valuable starting point for further investigations. In this case, the 
heterochronic mice presented significant changes in the circulating HSC, as the LT-HSC of old 
mouse origin, exposed to the young environment, recovered to original, youthful numbers, and 
balanced the myeloid bias. Similar result was obtained when co-culturing HPC with niche cells 
from young and old individuals.  Insulin-like growth factor-1, known longevity factor, also 
regulating differentiation, was found to have a role in aged niche function, that could be 
pharmacologically inhibited (Mayack, Shadrach, Kim, & Wagers, 2010).  
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A study by Vas and colleagues, presented a novel approach toward determining possible 
action of aged niche. By creating retrovirally infected SF91/IRES-eGFP dominant 
haematopoietic progenitor cells, of increased transplantation potential, they observed different 
homing capabilities in young and aged niche. Injected old mice showed significant skewing 
toward myeloid output out of transplanted cells, and general decrease in clonality (Vas, Senger, 
Dorr, Niebel, & Geiger, 2012) Indeed, not only PDGFRβ+ NG2+ mesenchymal cells, but also 
α-SMA-covered arteries and endomucin+ capillaries were significantly reduced in aged mice. 
Enhancement of Notch signalling pathway components in endothelial cells induced arteriole 
formation in aged individuals, leading to improvements in the stromal compartment, followed 
by increase in HSC numbers. Nevertheless, the functionality of HSC was not studied in these 
mice (Kusumbe et al., 2016). 
3.3 Inflammageing 
Low level of inflammation has been described in many organs in aged individuals, with 
increase of inflammatory cytokines levels correlated with morbidity (Ferrucci et al., 2005). It 
is postulated that this state, with self-descriptive name- inflammageing- is also an important 
factor in initiation and propagation of neurodegenerative diseases, and osteoporosis.  
Inflammation is a natural response of organism towards pathogens, tissue damage, and 
endogenous stimuli. Haematopoieitc compartment is tightly connected to inflammatory 
processes, as a producer of innate immune cells, that react to pathogens by production of 
chemokines and cytokines, such as interleukin (IL) 1β,IL-6 and IL-12, TNF-α, and CXCL-8, 
as well as  IL-4, IL-5, interferon (IFN)-γ, and TGF-β as a part of adaptive immunity (Denkinger, 
Leins, Schirmbeck, Florian, & Geiger, 2015). Not only immune cells, but also HSC express 
pattern recognition receptors required to identification of dangers (Takizawa, Boettcher, & 
Manz, 2012). Presence of the pathogen promotes HSC proliferation, egress to the bloodstream, 
and myeloid skewing. The same response occurs towards cytokines secreted by immune cells, 
as HSC express multiple cytokine receptors (Zhao et al., 2014). MSC are deeply involved in 
immunomodulation and express vast array of cytokines, inhibiting T cell function, proliferation 
of dendritic cells, B lymphocytes and natural killer cells (Nauta & Fibbe, 2007).  
In elderly patients, factors such as IL-6, IL-1 receptor antagonist, IL-18, fibrinogen, C-
reactive protein, all increase significantly, with IL-6 increase only in males (Ferrucci et al., 
2005). TNF was found to act through p55 TNF targeting receptor, and specifically target 
cycling HSC, impairing their ability of reconstitution when transplanted in immunodeficient 
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mice, and in CFU assay (Dybedal, Bryder, Fossum, Rusten, & Jacobsen, 2001). In patients with 
haematopoietic malignancies TNF-α plays a double role. When elevated, it fosters cancer cell 
survival and growth, simultaneously impeding growth of healthy progenitor cells (Kovtonyuk, 
Fritsch, Feng, Manz, & Takizawa, 2016). In homeostasis, pathogen presentation can influence 
quiescence and differentiation of HSC, as it happens in case of megakaryocytes. Emergency 
megakaryopoiesis in response to increased interferons, was found to occur by appearance stem-
like megakaryocyte primed progenitor cells (Haas et al., 2015). Taken together these data 
suggest that inflammatory cytokines elevated in older patients can be the major driver in 
skewing towards myeloid lineages, as most of them provoke such a bias. In mice, factors such 
as IL-1β, IL-6, IFN-γ, and TNF-α are significantly increased during ageing. Interestingly, their 
levels were found reduced in healthy long-lived individuals as compared to non-selected old 
mice, further suggesting the possible deteriorating effect of this basal inflammation (Arranz, 
Lord, & De la Fuente, 2010). 
Inflammation plays a role also in leukaemogenesis, as it was found involved in many types 
of cancer. Epidemiological study based in Sweden, revealed a correlation pattern with 1.3-fold 
increase of occurrence of MDS and AML in patients that came through infectious disease in 
years previous to onset (Kristinsson et al., 2011). Increased levels of IL-1β has a proliferation 
stimulating effect on AML cells, that translates also in growth promotion on leukaemic cells 
transplanted into mice (Carey et al., 2017).  
4 The aim of the study 
In this study we monitored changes occurring in the heamatopoietic compartment and in 
the HSC niche during ageing, in healthy mice and in mutant mice carrying inducible leukaemic 
potential. 
Materials and methods 
1 Mice 
LSL-NRASG12D Mx1-Cre with genotype <tm1Tyj>/J Tg(Mx1-cre)1Cgn/J were obtained 
thanks to courtesy of Dr Paloma García from University of Birmingham. Breeding colony is 
maintained in Charles River Laboratories (Germany). Mx1cre- were bred in the same 
conditions, to be assessed along leukaemic littermates, in order to investigate the same factors 
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in healthy ageing. Only male individuals were included in this study to overcome potential bias 
caused by different hormone levels.  
 
Figure 6 - Scheme of cre-recombinase-dependent excision of stop codone in Mx1 expressing cells, present in 
investigated mice model. 
Mx dynamin-like GTPase 1 (Mx1) promoter is activated in an interferon-dependent manner 
through injection of polyinosinic:polycytidylic acid (pIpC), promoting downstream expression 
of Cre-recombinase (Figure 6). pIpC is a synthetic RNA analog, interacting with Tool-like 
receptor 3, inducing high production of interferon (IFN)-α and –β by organism after injection 
(Fortier et al., 2004). To rule out the possible effect that pIpC inductor molecule can bear on 
haematopoietic compartment, the control mice, which did not bear the disease switch-on gene, 
were administered pIpC at the same time point as the transgenic counterpart. Inductor molecule 
was injected intraperitoneally in a 300µg single dosis.  
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Figure 7 - Illustration of experimental setting. Both Wild Type and Transgenic mice were injected pIpC (syringe) at 
the same time points in respective age groups. 
In order to analyse disease progression and the bone marrow microenvironment in 
different stages of life, comparable to human ageing, mice were sacrificed within specific 
timeframe, and divided into three subgroups, of young, middle aged and old (Figure 7). Number 
and life length of mice in respective subgroups is presented in Table 1.  
Table 2 - Number and average age of mice in each experimental group, at the time of pIpC injection and at the time 
of sacrifice. 
Group Number Duration of induction  Age of sacrifice 
Wild  Type 
Young 16 3,3 +/- 1,4 6,3 +/- 0,9 
Middle age 19 11,6 +/- 1,9 14,1 +/- 0,8 
Old 19 11,1 +/- 2,1 19,3 +/- 1,3 
Transgenic 
Young 16 3,3 +/- 1,4 6,1 +/- 1 
Middle age 17 11,2 +/- 1,3 14,3 +/- 1,1 
Old 17 10,4 +/- 1,3 18,3 +/- 0,9 
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2 Disease progression monitoring 
In order to monitor malignant transformation in transgenic mice, and changes during 
healthy ageing in control mice, mice blood was analysed regularly, and the same measurements 
were performed on blood aspired from the heart immediately after sacrifice. 
Peripheral blood was analyzed for complete blood count, white blood cells (WBC), red 
blood cells (RBC), haemoglobin (HGB), haematocrit (HCT), and platelets (PLT), using the 
fully automated Pentra XL80 analyzer (Horiba ABX, Montpellier, France).  
3 Analysis of bone marrow cell populations 
From each mice, bones responsible for main haematopoietic activity were extracted and 
processed to obtain single cell suspension, preserving physiological conditions. Bone marrow 
nucleated cells were processed from hip, tibia, upper spine, upper sternum and humerus of each 
mouse. Bones were crushed with PBS1X in a mortar, and filtered through a 40-μm cell 
strainer to obtain single cell suspension. Depletion of red blood cells by lysis in RBC Lysis 
buffer containing ammonium chloride, potassium carbonate, and EDTA for 10 min at 4 °C. 
Reaction was stopped with PBS with 2% fetal bovine serum (FBS). Similarly, bone marrow 
stromal cells from hip, lower spine, lower sternum and humerus were extracted, crushed and 
incubated in collagenase for 1 hour at 37 °C, on 65 rpm shaker. Cells were then filtered and 
lysed as described previously. The spleens were weighted and third part of each was obtained, 
homogenized and filtered before lysis. Cells suspended in PBS 2% FBS were then counted on 
CASY TT Cell Counter + Analyzer (OLS OMNI Life Science, Germany). 
3 × 106  of cells per sample were incubated with the dilution 1:100 of fluorescent antibody 
conjugates (Table 2.) in PBS 2%FBS and  analysed on LSR Fortessa flow cytometer (BD 
Biosciences, Franklin Lakes, NJ) equipped with FACSDiva Software (BD Biosciences). For 
stromal cells, biotinylated antibodies were used, consequently conjugated with fluorescently 
labelled streptavidin (1:100 dilutions).  To exclude dead cells, 1:1000 dilution in PBS 2%FBS 
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Table 3 - Antibodies used in flow cytometry 
Aim  Antibody Distributor 
Lymphocytes anti-B220-FITC (RA3-6B2), anti-CD3ε-PE-Cy5 (145-2C11), 
BD Biosciences 
Monocytes 
anti-CD11b-Alexa647 (M1/70), anti-Ly-6G-PE (1A8) 
anti-F4/80-FITC (BM8) eBioscience  (CA, USA) 
Stromal cells 
anti-CD63-PE (NVG-2),  anti-CD90.2 APC (53-2.1), 
anti-CD45.2-biotin (MEC 13.3), anti-Ter119-biotin (TER-119), 
BD Biosciences anti-CD31-biotin (104) 
streptavidin-APC-cy7 
3.1 Flow cytometry settings 
To define the population of interest, in all samples in population P1 debris was excluded 
basing on the size and complexity of the cells calculated through forward scatter. In P2 side 
scatter view enabled to exclude duplets, or other entities that did not suited approximated cell 
complexity. P3 was gated at the live cells population, excluding DAPI stained dead cells. 
Further, myeloid cells were defined by CD11b expression, and among them monocytes were 
measured by defining F4/80 positive and Gr1 high (Figure 8). 
 
Figure 8 - Gating of flow cytometry measurements based on expression of surface marker molecules CD11b-APC, 
GR1-PE and F4/80-Alexa488 
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In stromal cell analysis, CD45.2, Ter119 and CD31 were used as a negative selection 
tool, as they mark haematopoietic compartment, erythrocytes and endothelial cells (Figure 9). 
Remaining population, defined as stromal, were further analysed for expression of CD63 and 
CD90.2.  
 
Figure 9 - Gating of flow cytometry based on expression of surface marker molecules. Stromal cells were defined 
as CD31, CD45.2, and Ter119 negative. Among them CD63 and CD90-expressing populations were defined 
separately. 
3.2 Colony Forming Unit- Cell (CFU-C) assay 
Cells obtained in single cell suspension, from bone marrow and spleen, at the density of 4 
x 104 and 4 x 105 cells respectively in 2 ml of methylcellulose media were seeded in duplicates 
of 1ml per plate. Cells were then cultured for one week in 37°C incubator, and formed colonies 
were counted under 4x magnification in light microscope. Colonies were distinguished as 
accumulation of more than 50 cells, with visible nuclei-like concentration of cells in the central 
part of the colony, represented in Figure 10. 
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Figure 10 - Representative picture of methylcellulose bone marrow cell culture, with distinguishable colonies pointed 
by arrows. The size of cells varies as they can differentiate towards various lineages. 
4 RNA expression analysis 
RNA from cellular pellets was isolated accordingly to reagent distributor’s protocol with 
slight changes. Pellets were thawed and homogenized in volume of TRI-reagent (Sigma-
Aldrich, MI, USA) adjusted to the amount of frozen cells (10 or 5 millions). Following steps of 
chloroform- driven lysis and isopropanol gradient extraction were performed as suggested by 
protocol. Obtained RNA pellets were then washed twice in 0,5 µl of 70% ethanol, and dried on 
ice. RNA was then rehydrated in 11 µl of ultrapure water. RNA extraction purity was then 
measured on NanoDrop 2000 (Thermo Fisher Scientific, MA, USA), and only values 
A230/A260>1,8 A260/280>1,9 were considered valid.  RNA samples were then transcribed 
into cDNA with a use of High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher 
Scientific) according to manufacturer’s manual.  
qPCR was performed using 5µl of Power SYBR® Green PCR Master Mix (Thermofisher 
Scientific) with 0,075 µl of correspondent primers (listed in Table 3.) per each 5 µl of cDNA 
sample, loaded on 384-well PCR plate. Samples were run in Applied Biosystems™ 
QuantStudio™ 7 Flex Real-Time PCR System (Thermo Fisher Scientific) in software provided 
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by manufacturer. The expression level of each gene was determined using the standard curve 
method.  Delta Cp normalization was performed to Gapdh as a housekeeping gene. 
Table 4 - Sequence of primers used for qPCR gene expression analysis 
Gene Forward primer Reverse primer 
Gapdh GCATGGCCTTCCGTGTTC CCTGCTTCACCACCTTCTTGAT 
Il1b GAAATGCCACCTTTTGACAGTG TGGATGCTCTCATCAGGACAG 
Il1rn GAGAAACAACCAGCTCATTGC GGATGCCCAAGAACACACTATG 
casp1 TTGGAGCTCAAGTTGACCTCAG TGTCAGAAGTCTTGTGCTCTGG 
il1r1 TTACCCGAGGTCCAGTGGTA CCCCCGGAACGTATAGGACA 
nestin GTCAGATCGCTCAGATCCT GTGTCTGCAAGCGAGAGTTC 
gfap CGGAGACGCATCACCTCTG AGGGAGTGGAGGAGTCATTCG 
 
5 Statistical analysis 
All the statistical analysis was performed by use of GraphPad Prism 7 (GraphPad Software 
La Jolla, CA, USA). t-Student test was used to compare the mean values obtained between 
respective age groups. Results were presented with the standard error of the mean. 
Results 
1 Pathological phenotype was present among 
transgenic mice, and accelerated with age 
Phenotype of myeloid leukaemia in NRASG12D mice comprises augmented WBC, 
specifically monocytes, and splenomegaly in majority of individuals. In vitro test of HSC show 
that in AML their proliferative activity is significantly enhanced.  
To assess overall output of haematopoiesis in all the mice, peripheral blood cell counts 
were compared, as measured by Pentra Analyser at the time of sacrifice. Haematocrit, the 
volume percentage of red blood cells in whole blood, is measured indirectly by analyser, with 
result obtained after calculation of erythrocyte number multiplied by mean cell volume. As an 
internal control, haematocrit numbers in wild type were similar, whereas in transgenic mice 
small but significant decrease was noticeable only in the old group (Figure 11). 
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Figure 11 - Haematocrit percentage in peripheral blood at the time of sacrifice measured by Pentra Analyser. 
*p<0.05 
 Leukocytes or WBC counts in peripheral blood of transgenic mice were significantly 
elevated in all the transgenic groups in comparison to their wild type counterpart (Figure 12). 
This was the first criteria to diagnose disease in transgenic mice. 
 
Figure 12 - White blood cell counts of peripheral blood measured by Pentra Analyser. *p<0.05 **<0.01 ***<0.001  
 Among WBC, neutrophils, monocytes, and lymphocytes were counted separately. 
Neutrophils reflected the same trend of whole WBC compartment, although due to high 
variability among results for old transgenic individuals the differences were significant only in 
middle aged mice compared to control (Figure 13).  
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Figure 13 - Neutrophils in peripheral blood measured by Pentra Analyser. ***<0.001  
Monocytes presented a pattern of significant increase in all the age groups when 
compared to control, which is consistent with the NRASG12D-derived leukaemia phenotype. 
Pathological increase was remarkably enhanced during ageing (Figure 14).   
 
Figure 14 - Monocytes in peripheral blood measured by Pentra Analyser. *p<0.05 **<0.01 ***<0.001 
 In lymphocytes, decline occurred gradually in wild type mice, whereas no changes were 
seen in transgenic littermates. There was a significant increase in the number of cells when 
comparing middle aged transgenic and old mice with their respective control groups, due to the 
reduced numbers in the latter (Figure 15). 
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Figure 15 - Lymphocytes in peripheral blood measured by Pentra analyser *p<0.05 **<0.01  
2 Cellularity of spleen significantly increased in 
transgenic mice 
In mice, splenomegaly, is a characteristic typical in development of NRASG12D leukaemia 
and reflects mobilization of cells to the spleen. Indeed, Mx1cre+ mice had significantly higher 
cell counts in entire spleens, when comparing with age-matched wild type counterparts. Within 
transgenic group, ageing caused a notable increase in cell amounts, which occurred gradually 
(Figure 16).  
When culturing the cells from spleen on methylcellulose media, colony forming units 
elevated drastically in transgenic mice. Moreover, in transgenic old individuals, numbers of 
progenitors in culture showed a trend toward significant increase in comparison to both young 
and middle age transgenic, suggesting mobilization of these cells particularly during old age 
(Figure 17).  
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Figure 16 - CASY counts of live cells in a suspension, calculated as a total number of cells in entire spleen **<0.01 
***<0.001  
 
Figure 17 - CFU-C counted from methylcellulose culture of 2 x 104 cells. ***<0.001  
3 Total counts of cells in bone marrow increased, as 
well as HSPC CFU-C forming capability  
Bone marrow cellularity was also found to be elevated in transgenic mice in comparison 
to control, when measuring live cells obtained in the suspension from crushed and filtered 
bones. The numbers significantly increase during ageing, in both groups (Figure 18).  
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Figure 18 - CASY counts of live cells in suspension, calculated as a total number of cells in entire bone marrow 
*p<0.05  **<0.01 ***<0.001 
 Functional assay proved a significant increase of colony-forming ability in transgenic 
mice, which is consistent with known leukaemic phenotype, particularly in the old group. 
Additionally, in both groups, ageing caused a pronounced increase in the number of progenitors 
in culture (Figure 19). 
 
Figure 19 - CFU-C counted from methylcellulose culture of 2 x 105 cells. *p<0.05  **<0.01 ***<0.001 
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4 Bone marrow myeloid cells present specific changes 
with age 
White blood cells residing in the bone marrow were isolated and analysed by flow 
cytometry. CD11b, integrin αM chain complement receptor, marks predominantly monocytes 
and macrophages, and is also expressed in other myeloid lineage cells. Myeloid cells are 
significantly increased during ageing, and augmented with age in transgenic versus wild type 
mice (Figure 20). 
  
Figure 1 - Number of CD11b expressing cells among bone marrow nucleated cells, measured by flow cytometry. 
**<0.01 ***<0.001 
  
Among them monocytes, defined based on Gr-1 and F4/80 expression, were 
significantly increased between wild type and transgenic older individuals. Moreover, within 
the genetically identical groups, a significant increase of this cells was found, in older mice 
compared to young (Figure 21). 
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Figure 21 - Number of monocytes defined as CD11b+ Gr1+F4/80- among bone marrow nucleated cells, measured 
by flow cytometry. *p<0.05 **<0.01 ***<0.001 
5 Stromal cells show a decreased trend during ageing 
CD63, the marker of stromal cells skewing towards osteoblastic lineage but also enriched 
in nestin-expressing cells, presents uneven distribution in the cohort. It is elevated in middle 
aged mice, and drops to the same level as in young, in old controls. In transgenic mice, the cells 
showed a trend of steady decrease with age, likely not significant due to high variability (Figure 
22, left panel).  
CD90 is the most commonly expressed marker within stromal compartment, which targets 
cells with not fully differentiated status, particularly fibroblasts and nestin-expressing cells. 
Cells with this marker significantly diminished in old wild type mice. In transgenic mice, again 
a trend of decrease can be observed (Figure 22, right panel).  
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Figure 22 - Populations of stromal cells in bone marrow treated with collagenase. Expression of CD63 (left) and 
CD90 (right) measured by flow cytometry. *p<0.05 
As a supplemental approach, level of nestin gene expression was measured in bone marrow 
nucleated cells (Figure 23). The differences were not significant, but a clear decreasing trend 
can be noted during ageing, with a pattern similar to CD63 cell numbers.  
 
Figure 23 - Expression of nestin gene measured by qPCR, n=6 per each group Standard deviation measured by t- 
student test. No significant differences were found 
Expression of Gfap gene was also analysed, to provide hints on the status of Schwann cells 
in the bone marrow. Extensive variability of gene expression profiles does not allow to observe 
any changes, although a trend to reduction is observed in old mice (Figure 24). 
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Figure 24 - Expression of Gfap gene measured by qPCR, n=6 in each group. Standard deviation measured by t- 
student test. No significant differences were found 
6 Differential expression patterns of genes involved in 
inflammatory processes 
To investigate the inflammatory status of experimental cohort, gene expression analysis 
was performed by real-time PCR. IL-1β, followed an increase in both wild type and transgenic 
mice during ageing, which was significant only in the old transgenic group. Caspase-1, enzyme 
responsible for IL-1β activation, was expressed in a similar pattern, and was significantly 
elevated in older individuals, both control and transgenic (Figure 25). 
 
 
Figure 25- Expression of IL1β and caspase-1 genes measured by qPCR, n=6 per each group Standard deviation 
measured by t- student test *p<0.05   
 IL-1 receptor and its antagonist are important factors modulating HSC. IL-1 receptor 
expression was significantly increased in old wild type mice, but not in the transgenic group. 
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Figure 26 - Expression of IL-1r and IL-1rn genes measured by qPCR, n=6 per each group. Standard deviation 
measured by t- student test. *p<0.05  **<0.01 ***<0.001 
Discussion 
  The Mx1-Cre, LSL-NrasG12D mice develop a mild and chronic myeloproliferative 
disorder that may or not transform to lethal leukaemia (Li et al., 2011). However, NrasG12D 
mutation is frequent in MDS and AML in humans. The reasons for this different phenotype are 
unknown, and may comprise both additional mutations and/or changes in the bone marrow 
microenvironment. Here, we have analysed ageing as a potential driver of leukaemic 
transformation. The mutation has a bimodal effect in mouse cells, as it can either enhance or 
decrease the repopulating and proliferating potential in different HSC-GFP populations, which 
has to be taken under consideration when interpreting HSC analysis results from this mice (Li 
et al., 2013). Middle aged and old subgroups of mice had similar time of disease development, 
as all of them were sacrificed around 11 months after induction. In this way, the old subgroup 
could be considered a good model for ageing where both the microenvironment and the 
haematopoietic system may have acquired some age-related changes by the time the NRAS 
mutation was induced, as the pIpC injection happened later in the life of the animals. It also 
enabled to avoid haematological insufficiency-associated mortality that tends to occur in Mx1-
Cre, LSL-NrasG12D mice 15 months after the induction (Li et al., 2011). 
 Peripheral blood results show significant changes in WBC compartment, which is in 
accordance with previously described data on this model. Haematocrit of the cohort, considered 
as an internal control, only showed little decrease in the transgenic old mice, which can be 
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expected since it is a percentage of volume of erythrocytes to entire blood volume, and in old 
transgenic mice, this ratio could have been altered by increased levels of WBC. Neutrophils 
showed a pattern of constant increase in transgenic mice, in parallel to the pattern of disease. 
Monocytes, as a main output of myeloid mutant cells, show a significant increase only in 
transgenic mice, particularly relevant in the old age. Decrease of lymphocytes with age in wild 
type mice is consistent with reduction of naïve lymphocytes in human blood (Lin et al., 2016). 
In the transgenic mice, age does not seem to induce a clear trend. Elevated lymphocytes levels 
can be associated with higher numbers of B-cells, which can occur as a side effect of the 
increased proliferation of progenitors in the NRASG12D model. Actually, NRASG12D seem to 
mask the effect of ageing on this cell population, as putatively higher numbers of lymphocytes 
in middle-aged and old transgenics seem to be resulting from the reduced numbers of these 
cells in their healthy counterparts. It remains to be seen whether the function of these cells is 
also preserved. 
Elevated spleen cellularity indicates a mobilization phenotype of progenitors likely due 
to bone marrow incapacity to home the enlarged cell populations. Haematopoietic cells of 
various lineages and stages of development egress into circulation and home in the spleen, 
causing splenomegaly. CFU-C assay proved excessively, that there is a functional HSC 
population within cells residing in the spleen, minimal in the wild type, which augments 
through ageing of the transgenic mice, and it is dramatically elevated in old subgroup. This 
indicates pronounced egress of mutant HSC and abnormal extramedullary haematopoiesis in 
these age mice. Interestingly, abnormal extramedullary haematopoiesis is a sign of malignancy 
or invasiveness in AML. 
The amount of cells in bone marrow was found to significantly escalate during ageing, 
which can be attributed to increased HSC manifested in CFU-C culture. Both assays mirrored 
the same significant changes, as in wild type there is a stable increase, proportionally elevated 
in transgenic mice as result of the NRASG12D mutation. As in spleen, in cells derived from bone 
marrow, transgenic old mice had remarkably higher HSC CFU potential than all the other, 
indicating influence of age related changes for development of the disease. Expansion of 
phenotypically defined HSC emerge with ageing, but they do not preserve their functionality, 
that is in fact decreased (Sudo et al., 2000). To specifically assess the functionality of aged 
HSC, cells should be validated in vivo, by serial transplantations, as this is the only assay fully 
defining their long-term activity potential. 
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CD63 traces cells that in vivo present osteoblastic potential (Sacchetti et al., 2007), and 
it is also a marker enriched in nestin-expressing cells. In our setting, CD63 positive cells in wild 
type mice were shown to increase in the middle age and then again get to the basal level in old 
mice, which may be associated with osteoprogenitor decrease among old mice (T. L. Chen, 
2004). High variability among the numbers of these stromal cells in transgenic mice does not 
allow to obtain any conclusion from our study at this stage. Mesenchymal extracellular vesicles 
abundantly express CD63, and carry a bone regenerating activity and lineage commitment 
influence (Martins, Ribeiro, Martins, Reis, & Neves, 2016). They were also reported to carry 
cytokines and growth factors that influence malignant transformation in multiple myeloma 
(Wang et al., 2013). Therefore, changes in CD63-expressing cells shall be monitored 
thoroughly in future studies, as well as their secretion of vesicles. 
CD90 is a marker of osteochondrogenic cells that are particularly enriched in nestin-
expressing cells (Isern et al., 2014) and fibroblasts. In stromal cells from old wild type mice, 
CD90 cells remarkably decline with age. The same trend appears gradually in the transgenic 
mice, masked by a high deviation among individuals from the same group of age. Given the 
importance of mesenchymal stromal cells for HSC maintenance, this age-related decrease 
should be followed up in future studies, as it may influence the aggravated leukaemic 
progression in the old group.  
Nestin gene expression was not significantly downregulated in this cohort, but it showed 
a trend to decline in transgenic mice. It is important to note that results of qPCR may be masked, 
as the analysis was performed on the entire bone marrow nucleated cell compartment. To define 
specifically the mesenchymal component enriched in nestin, sorted stromal cells should be 
used. Additionally, nestin-gfp mice could be used to determine the numbers of these cells within 
the stromal compartment through flow cytometry. As a matter of fact, in a recent study by 
Maryanovich and collegues, the nestin+ compartment was found dramatically reduced during 
ageing in mice, as a result of adrenergic nerve fibre insufficiency. Adrenergic innervation 
measured by tyrosine hydroxylase, and its synaptophysin+ synapses are reduced with ageing 
(Maryanovich et al., 2018).  
Here, we found no changes in Gfap gene expression, although a trend towards decreased 
levels is observed in the old age. This also corresponds to the recently published data, as GFAP 
reflect the state of Schwann cell compartment. Again, including all the populations of bone 
marrow nucleated cells in the analysis can mask expression by Schwan cells and be the cause 
of high deviation within the groups. Degradation of SNS in bone marrow was previously 
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reported in MPN (Arranz et al., 2014) and AML (Hanoun et al., 2014), and now confirmed in 
ageing (Maryanovich et al., 2018). Previous data from our group shows that this mouse model 
also characterizes by the neural disruption in femora, studied by immunofluorescence (Bernal, 
Serrula, Villatoro, & Arranz, 2017). It is reasonable to hypothesize that this dysregulation has 
an impact on the reduction of stromal compartment represented here by cytometry data. 
Elevated levels of IL-1β protein were described in ageing mice (Arranz et al., 2010), 
and here we have found IL-1β expression elevated in aged wild type mice. The same pattern 
occurred in transgenic mice, without significant changes. Caspase-1, responsible for IL-1β 
activation was found elevated too, which show a possible pathway of enhancement of this 
protein molecular availability. Lack of changes in this cytokine expression among transgenic 
bone marrow nucleated cells does not necessarily mean similar cytokine activity, as protein 
levels may be influenced by multiple additional factors. Gene expression measured by PCR 
provides only phenotypic description of investigated cells, and does not fully represent their 
functionality. The same applies to measurement of expressed IL-1 receptor and its antagonist. 
IL-1 receptor shows increased expression in old wild type mice, change that was not observed 
in transgenic mice, and poses an interesting point for further studies. Interestingly, the 
antagonist expression was found to follow the same patter in both controls and transgenics. 
Nevertheless, expression does not reflect functionality of the protein as competitor, and its 
accumulation could occur in any cell subset.  Alternative pathways of receptor activation also 
should be taken under consideration in the future. 
The aim of the present work was to provide hints on the effects of ageing to leukaemic 
transformation, either cell-autonomously or through the niche. Our data indicate that disease 
progression is significantly aggravated in the old age, suggesting that this is indeed a factor that 
confers invasiveness. Further, we show reductions in the CD90-positive stromal cell population 
that occur with healthy ageing in the old, and correlate with disease severity. Future studies 
should test the specific impact of this event in leukaemia transformation. Extensive research 
focused on ageing in HSC often omits the microenvironment context. Since the bone marrow 
niche is becoming more and more elucidated, and the network of cellular interplay within it is 
painted more clearly and detailed, its role in ageing and malignancies should be investigated 
profoundly, as these two may have cumulative effects. There are several niche factors that have 
been investigated as potential therapeutic agents for pathological states. Perhaps some of them 
should be investigated as supplements to increase longevity of functional haematopoietic 
system, or prevent malignancy development.  
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